Magda Sobieszczyk
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- HIV/AIDS drug development and treatment 2
- HIV/AIDS Research and Interventions 2
- Tuberculosis Research and Epidemiology 2
- Antimicrobial Resistance in Staphylococcus 1
- Virology 4
- HIV Research and Treatment 4
- Co-authors
- Vinai Suriyanon (1 shared paper)Scott Parker (1 shared paper)John H. Eldridge (1 shared paper)M. Cardinali (1 shared paper)Lindsey R. Baden (1 shared paper)Artur Olhovetchi Kalichman (1 shared paper)Spyros A. Kalams (1 shared paper)Marnie Elizaga (1 shared paper)
- Journals
- AIDS Research and Human Retroviruses (2 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)The International Journal of Tuberculosis and Lung Disease (1 paper)PLoS ONE (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- United StatesThailandPeru
In The Last Decade
Magda Sobieszczyk
7 papers receiving 237 citations
Peers
Comparison fields: 5 of 46
- Molecular Medicine 95
- Applied Microbiology and Biotechnology 23
- Virology 48
- Pharmacology 79
- Critical Care and Intensive Care Medicine 18
Countries citing papers authored by Magda Sobieszczyk
This map shows the geographic impact of Magda Sobieszczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magda Sobieszczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magda Sobieszczyk more than expected).
Fields of papers citing papers by Magda Sobieszczyk
This network shows the impact of papers produced by Magda Sobieszczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magda Sobieszczyk. The network helps show where Magda Sobieszczyk may publish in the future.
Co-authors
The 25 scholars most cited alongside Magda Sobieszczyk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 118 | |
| 2 | 2012 | 90 | |
| 3 | 2010 | 15 | |
| 4 | 2010 | 11 | |
| 5 | 2017 | 4 | |
| 6 | 2014 | 1 | |
| 7 | 2014 | 1 |
About Magda Sobieszczyk
Magda Sobieszczyk is a scholar working on Infectious Diseases, Virology, Epidemiology, Immunology and Pharmacology, having authored 7 papers that have together received 240 indexed citations. Recurring topics across this work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (2 papers), HIV/AIDS Research and Interventions (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Tuberculosis Research and Epidemiology (2 papers), Antimicrobial Resistance in Staphylococcus (1 paper), Hepatitis B Virus Studies (1 paper) and Biosimilars and Bioanalytical Methods (1 paper). The work is most often cited by research in Molecular Medicine (95 citations), Applied Microbiology and Biotechnology (23 citations), Virology (48 citations), Pharmacology (79 citations) and Critical Care and Intensive Care Medicine (18 citations). Magda Sobieszczyk has collaborated with scholars based in United States, Thailand and Peru. Frequent co-authors include Vinai Suriyanon, Scott Parker, John H. Eldridge, M. Cardinali, Lindsey R. Baden, Artur Olhovetchi Kalichman, Spyros A. Kalams, Marnie Elizaga, David B. Weiner and Xia Jin. Their work appears in journals such as AIDS Research and Human Retroviruses, JAIDS Journal of Acquired Immune Deficiency Syndromes, The International Journal of Tuberculosis and Lung Disease, PLoS ONE and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.